RedHill Biopharma (RDHL) Assets Average (2023 - 2024)
RedHill Biopharma (RDHL) has disclosed Assets Average for 2 consecutive years, with $20.5 million as the latest value for Q4 2024.
- Quarterly Assets Average fell 77.41% to $20.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Dec 2024, down 77.41% year-over-year, with the annual reading at $20.5 million for FY2024, 77.41% down from the prior year.
- Assets Average for Q4 2024 was $20.5 million at RedHill Biopharma, down from $91.0 million in the prior quarter.
- The five-year high for Assets Average was $91.0 million in Q4 2023, with the low at $20.5 million in Q4 2024.